← Eichor
Condition: Neovascular Age Related Macular Degeneration Nvamd Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Neovascular Age Related Macular Degeneration Nvamd

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Phase 2/Phase 3 · 91 location(s) · EyeBiotech Ltd. · NCT07440225A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO
Phase 2 · 49 location(s) · EyeBiotech Ltd. · NCT07205887A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Phase 2/Phase 3 · 63 location(s) · EyeBiotech Ltd. · NCT07496567
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.